|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 October 2017 |
|
Main ID: |
NCT00423358 |
|
Date of registration:
|
17/01/2007 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Treatment of Hypovitaminosis D in Rheumatoid Arthritis
|
|
Scientific title:
|
Treatment of Hypovitaminosis D in Rheumatoid Arthritis |
|
Date of first enrolment:
|
February 2005 |
|
Target sample size:
|
22 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT00423358 |
|
Study type:
|
Interventional |
|
Study design:
|
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Karen E Hansen, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Wisconsin, Madison |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Rheumatology
Exclusion Criteria:
- Bisphosphonate therapy
Age minimum:
18 Years
Age maximum:
90 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Hypovitaminosis D
|
|
Rheumatoid Arthritis
|
|
Intervention(s)
|
|
Dietary Supplement: Vitamin D
|
|
Dietary Supplement: placebo
|
|
Primary Outcome(s)
|
|
Parathyroid Hormone Level
[Time Frame: 1 Year]
|
|
Secondary Outcome(s)
|
|
Bone Mineral Density
[Time Frame: 1 Year]
|
|
Short Form 36 Survey
[Time Frame: 1 Year]
|
|
Secondary ID(s)
|
|
2004-0011
|
|
K23AR050995
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|